{"id":47310,"date":"2004-05-21T00:00:00","date_gmt":"2004-05-20T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/crystax-gains-a-capital-increase-of-2-1-million-euros\/"},"modified":"2020-11-18T14:51:22","modified_gmt":"2020-11-18T13:51:22","slug":"crystax-gains-a-capital-increase-of-2-1-million-euros","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/","title":{"rendered":"Crystax gains a capital increase of 2.1 million Euros"},"content":{"rendered":"

”<\/p>\n

\n
\n
\n\t\t\t\t\t\t<\/a>
\n\t\t\t\t\t\t\n\t\t\t\t\t<\/div><\/div><\/div>\n

\t\t\tCrystax Pharmaceuticals is the leading company in Spain in the use of a technology platform for drug discovery and design. It carries out 3D resolution of the structures of pharmacological targets, which allows the identification of the fastest way to optimize a given drug. This new investment ensures the continuity of the company’s business plan for the coming years and the continuation of the research developed since its set up. <\/p>\n

Crystax specializes in the development of anti-cancer drugs in its laboratory facilities at the Parc Cientific de Barcelona. The company focuses on the optimization of this process through reducing the development time and increasing its efficacy in initial phases. Crystax also collaborates with other companies in the sector by providing services based on in-house technology to facilitate drug discovery. At present, Crystax holds contracts with several leading pharmaceutical companies in Europe and in Spain, such as Almirall Prodesfarma and the Esteve Laboratories. <\/p>\n

About Crystax Pharmaceuticals <\/b> <\/p>\n

Crystax Pharmaceuticals was set up in mid 2002 by the researchers Joan Aymami (Universitat Polit\u00e8cnica de Catalunya- Technical University of Catalonia), and Miquel Coll (Consell Superior d’Investigacions Cient\u00edfiques- Spanish Council for Scientific Research) after the discovery of molecules with anti-caner properties that act on DNA. <\/p>\n

Furthermore, Crystax uses synchrotron particle accelerators, which produce light a million times brighter than any conventional x-ray source. At present, a synchrontron accelerator is being built in El Vall\u00e8s (Barcelona), and is expected to become operational in 2008. <\/p>\n

CIDEM. Generalitat de Catalunya <\/p>\n

View full article<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"

Crystax Pharmaceuticals, a Spanish technology-based company devoted to drug discovery and design founded in 2002, has secured financial support from the companies Invertec, Najeti Capital (leading investor), and Barcelona Empr\u00e8n. In this operation, Nateji Capital will contribute 1.5 million euros, and Invertec and Barcelona Empr\u00e8n will provide 300,000 euros each. This financial agreement is the first of its kind in the biotech sector. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-47310","post","type-post","status-publish","format-standard","category-uncategorized"],"acf":[],"yoast_head":"\nCrystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Crystax Pharmaceuticals, a Spanish technology-based company devoted to drug discovery and design founded in 2002, has secured financial support from the companies Invertec, Najeti Capital (leading investor), and Barcelona Empr\u00e8n. In this operation, Nateji Capital will contribute 1.5 million euros, and Invertec and Barcelona Empr\u00e8n will provide 300,000 euros each. This financial agreement is the first of its kind in the biotech sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2004-05-20T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-18T13:51:22+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Crystax gains a capital increase of 2.1 million Euros\",\"datePublished\":\"2004-05-20T23:00:00+00:00\",\"dateModified\":\"2020-11-18T13:51:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1085579785777.bmp\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/\",\"name\":\"Crystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1085579785777.bmp\",\"datePublished\":\"2004-05-20T23:00:00+00:00\",\"dateModified\":\"2020-11-18T13:51:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1085579785777.bmp\",\"contentUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1085579785777.bmp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/crystax-gains-a-capital-increase-of-2-1-million-euros\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crystax gains a capital increase of 2.1 million Euros\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/","og_locale":"en_US","og_type":"article","og_title":"Crystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona","og_description":"Crystax Pharmaceuticals, a Spanish technology-based company devoted to drug discovery and design founded in 2002, has secured financial support from the companies Invertec, Najeti Capital (leading investor), and Barcelona Empr\u00e8n. In this operation, Nateji Capital will contribute 1.5 million euros, and Invertec and Barcelona Empr\u00e8n will provide 300,000 euros each. This financial agreement is the first of its kind in the biotech sector.","og_url":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2004-05-20T23:00:00+00:00","article_modified_time":"2020-11-18T13:51:22+00:00","og_image":[{"url":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp","type":"","width":"","height":""}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Written by":"adminpcb","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Crystax gains a capital increase of 2.1 million Euros","datePublished":"2004-05-20T23:00:00+00:00","dateModified":"2020-11-18T13:51:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/"},"wordCount":254,"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/","url":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/","name":"Crystax gains a capital increase of 2.1 million Euros - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp","datePublished":"2004-05-20T23:00:00+00:00","dateModified":"2020-11-18T13:51:22+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#primaryimage","url":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp","contentUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1085579785777.bmp"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/en\/crystax-gains-a-capital-increase-of-2-1-million-euros\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"Crystax gains a capital increase of 2.1 million Euros"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/47310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=47310"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/47310\/revisions"}],"predecessor-version":[{"id":52036,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/47310\/revisions\/52036"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=47310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=47310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=47310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}